0.68 - 0.75
0.33 - 0.86
13.06M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-25.95%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-48.58%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-122.15%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-122.15%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-112.71%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-111.92%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-111.92%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
5.84%
Share reduction more than 1.5x 0376.HK's 15.21%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
5.85%
Diluted share reduction more than 1.5x 0376.HK's 15.21%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-1.18%
Dividend reduction while 0376.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
21.66%
OCF growth under 50% of 0376.HK's 78.53%. Michael Burry might suspect questionable revenue recognition or rising costs.
22.08%
FCF growth under 50% of 0376.HK's 106.55%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-40.24%
Negative 10Y revenue/share CAGR while 0376.HK stands at 1035.12%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-52.05%
Negative 5Y CAGR while 0376.HK stands at 2984.21%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
20.63%
3Y revenue/share CAGR under 50% of 0376.HK's 3723.98%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-6853.77%
Negative 10Y OCF/share CAGR while 0376.HK stands at 390.90%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-29.54%
Negative 5Y OCF/share CAGR while 0376.HK is at 703.80%. Joel Greenblatt would question the firm’s operational model or cost structure.
-75.23%
Negative 3Y OCF/share CAGR while 0376.HK stands at 892.05%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-114.02%
Negative 10Y net income/share CAGR while 0376.HK is at 389.55%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-118.06%
Negative 5Y net income/share CAGR while 0376.HK is 229.59%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-148.19%
Negative 3Y CAGR while 0376.HK is 249.10%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
90.48%
Below 50% of 0376.HK's 487.62%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-2.50%
Negative 5Y equity/share growth while 0376.HK is at 89.45%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
38.48%
Below 50% of 0376.HK's 111.49%. Michael Burry suspects a serious short-term disadvantage in building book value.
-24.01%
Cut dividends over 10 years while 0376.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-60.78%
Negative 5Y dividend/share CAGR while 0376.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-60.06%
Negative near-term dividend growth while 0376.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-20.45%
Firm’s AR is declining while 0376.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
6.44%
Inventory growth of 6.44% while 0376.HK is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
-4.93%
Negative asset growth while 0376.HK invests at 6.61%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
8.83%
Positive BV/share change while 0376.HK is negative. John Neff sees a clear edge over a competitor losing equity.
7.92%
We have some new debt while 0376.HK reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
15.24%
R&D growth of 15.24% while 0376.HK is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
-27.52%
We cut SG&A while 0376.HK invests at 6.72%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.